Kailera Therapeutics Inc.
KLRA | NASDAQ
$12.65
-$0.21 (-1.63%)
Nov 2, 2026, 10:44 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 |
|---|---|---|
Net Income | -190.17M | -78.87M |
Depreciation & Amortization | 202K | 101K |
Stock-Based Compensation | 12.28M | 3.94M |
Other Working Capital | 22.35M | 7.96M |
Other Non-Cash Items | -2.34M | -951K |
Deferred Income Tax | n/a | n/a |
Change in Working Capital | 34.19M | 7.47M |
Operating Cash Flow | -145.84M | -68.31M |
Capital Expenditures | n/a | n/a |
Cash Acquisitions | n/a | n/a |
Purchase of Investments | -738.26M | -48.45M |
Sales Maturities Of Investments | 190.08M | 71.3M |
Other Investing Acitivies | n/a | n/a |
Investing Cash Flow | -548.18M | 22.85M |
Debt Repayment | n/a | n/a |
Common Stock Repurchased | n/a | n/a |
Dividend Paid | n/a | n/a |
Other Financial Acitivies | -4.88M | -3.04M |
Financial Cash Flow | 664.05M | -2.98M |
Net Cash Flow | -29.97M | -48.44M |
Free Cash Flow | -145.84M | -68.31M |
Adj. Free Cash Flow | -158.12M | -72.25M |
Maintenance CapEx | n/a | n/a |
Growth CapEx | n/a | n/a |
Owner Earnings | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove KLRA